NDC Compounded Drug 71449-091-43 Bevacizumab

Injection, Solution Intraocular

Table of Contents

    1. Compounded Product Information
    2. NDC Crossover Products Matching Bevacizumab
    3. Frequently Asked Questions

Compounded Drug Product Information

NDC Product Code 71449-091
NDC Package Code 71449-091-43
11-Digit NDC Billing Format NDC Format for Billing
For insurance billing purposes the Centers for Medicare & Medicaid Services (CMS) created an 11 digit NDC derivative identifier. If the NDC Package code is less than 11 digits the code must be padded with leading zeros. The leading zeros must be added to the appropriate segment to create a 5-4-2 configuration.		 71449009143
Package Description .1 mL in 1 SYRINGE, PLASTIC
Product Type What kind of product is this?
Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.		 Human Compounded Drug
Proprietary Name What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.		 Bevacizumab
Non-Proprietary Name What is the Non-Proprietary Name?
The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.		 Bevacizumab
Substance Name What is the Substance Name?
An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.		 Bevacizumab
Usage Information Product Usage Information
The drug use information is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate. This information is not individual medical advice and does not substitute for the advice of a health care professional. Always ask a health care professional for complete information about this product and your specific health needs.		 This medication is a man-made antibody (IgG1) used to treat various types of cancer. This drug works by blocking a certain protein (vascular endothelial growth factor-VEGF) thereby decreasing the blood supply to the tumor and slowing tumor growth. This monograph is about the following bevacizumab products: bevacizumab, bevacizumab-awwb, and bevacizumab-bvzr.
Dosage Form Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Route Name Intraocular - Administration within the eye.
Marketing Category OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Code 71449
Labeler Name What is the Labeler Name?
Name of Company corresponding to the labeler code segment of the Product NDC.		 Denver Solutions, Llc Dba Leiters Health
Substance Name Bevacizumab
Active Ingredients Information 25 mg/1 mL
Reporting Period 2021-2

NDC Crossover Products Matching Bevacizumab

NDC crossover of Bevacizumab with NDC 71449-091 a human compounded drug with other similar products matching the same substance name (Bevacizumab) and the same administration route (intraocular) or dosage form (injection, solution).

Frequently Asked Questions

What is the NDC number assigned to Bevacizumab?

Bevacizumab was assigned by its manufacturer with NDC product code 71449-091. This product is a drug classified as a human compounded drug. Compounded drugs are medications created by combining or altering existing drugs to meet the specific needs of certain patients. The NDC directory only includes information about compounded drugs from facilities that choose to assign NDC numbers to their products.

Which are the NDC package codes for Bevacizumab?

The NDC package code 71449-091-43 was assigned to a .1 mL in 1 SYRINGE, PLASTIC of bevacizumab administered intraocular via injection, solution.

Who manufactures this product?

Bevacizumab is manufactured by an outsourced facility and labeled by Denver Solutions, Llc Dba Leiters Health. All compounded drugs included in the NDC directory are classified as "Outsourcing Facility Compounded Human Drug Product (Exempt from Approval Requirements)". Outsourcing facilities are a type of drug compounding facility regulated under Section 503B of the FD&C Act could be eligible for exemptions from drug registration if they meet all the conditions specified under Section 503B.

Which are the NDC crossover matchings for this product?

We found 2 matching products that have the same substance, dosage form and administration route. The matching products are manufactured by Denver Solutions, LLC dba Leiters Health with NDC product codes 71449-091-44 and 71449-091-98.